A start-up developing a neurostimulation system that could help restore movement over paralyzed limbs has bagged €26m ($29.4m) in a venture financing round, the largest device-related series A of 2016 so far.
G-Therapeutics is a spin-off from Switzerland’s Ecole Polytechnique Fédérale de Lausanne (EPFL). Its technology stems from 15 years of research...





